Calcium plays a pivotal role in the human body, particularly in bone metabolism, an area of interest for healthcare professionals. This article elucidates the integral role of calcium in bone metabolism and its implications for medical practice.
Calcium is the primary mineral component of the bone, accounting for approximately 99% of the body's total calcium. It is essential for bone formation, remodeling, and maintenance. During bone metabolism, calcium is continuously deposited and resorbed, a process regulated by hormones such as parathyroid hormone (PTH) and calcitonin.
Understanding calcium's role in bone metabolism is vital in managing osteoporosis. This condition, characterized by reduced bone mass and structural deterioration, leads to increased fracture risk. Adequate calcium intake is a cornerstone in osteoporosis prevention and treatment, along with vitamin D and weight-bearing exercise.
Calcium supplementation is commonly recommended for populations at risk of inadequate dietary intake, such as post-menopausal women and the elderly. However, healthcare professionals must consider individual patient factors, as excessive calcium supplementation can lead to hypercalcemia and increased risk of cardiovascular events.
Healthcare professionals should routinely assess patients' calcium intake and ensure it aligns with recommended dietary allowances. Additionally, understanding the interplay between calcium, vitamin D, and PTH can help manage conditions like secondary hyperparathyroidism, common in chronic kidney disease.
In conclusion, calcium's role in bone metabolism is multifaceted and crucial to skeletal health. As healthcare professionals, we must understand this role to effectively prevent and manage bone-related diseases. Further research is needed to optimize calcium supplementation strategies and understand the complex interactions between calcium and other factors in bone metabolism.
1.
Discovery reveals protein involved in Parkinson's disease also drives skin cancer
2.
The prognosis of the Slovakian PM; Kate Middleton's treatment; and drug test cheating.
3.
We Don't Always Know What's 'Best' for Our Patients
4.
New tumor therapy approach reduces costs and side effects while increasing accessibility
5.
Dual-action mRNA vaccine takes aim at aggressive skin cancer
1.
The Evolving Arsenal: A 2025 Review of Antibody-Drug Conjugates and the Future of Precision Oncology
2.
Case Study: Combining Targeted Therapy with Immunotherapy for Metastatic Melanoma
3.
Anion Gap: The Simple Calculation That Reveals Much About Your Health
4.
Contemporary Methods in Hematology Across Clinical Settings
5.
Unlocking the Potential of Cytarabine: A New Era of Cancer Treatment
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Lorlatinib in the Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)
2.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VI
3.
An Eagles View - Evidence-based discussion on Iron Deficiency Anemia- Further Talks
4.
Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option
5.
Current Scenario of Cancer- Palliative Care to Close the Care Gap
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation